Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1965.
website : http://www.wibp.com.cn/.
Main Product : Its main products include vaccines and biological products.
Company Profile
The company is committed to improving public health through the development of vaccines and other biological products.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1994
website : www.tianyuanbio.com
Main Product : Heparin Sodium, Heparin Calcium, Enoxaparin Sodium, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a renowned pharmaceutical company specializing in the production of heparin products. Established in 1994, the company has grown to become a key player in the global pharmaceutical market, with a wide range of high-quality products and a strong competitive position. With a large workforce and a strong presence in both domestic and international markets, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. continues to innovate and lead in the field of bio-pharmaceuticals.
Sinovac Biotech Co., Ltd.
Establishment time : 2001
website : www.sinovac.com
Main Product : vaccines, including CoronaVac for COVID-19
Company Profile
Sinovac Biotech Co., Ltd. is a leading biopharmaceutical company based in China, specializing in the research, development, production, and commercialization of vaccines. Established in 2001, Sinovac has become a key player in the global vaccine market, with a focus on preventing infectious diseases. The company's main product, CoronaVac, has gained international recognition for its effectiveness in combating the COVID-19 virus. With a medium-sized company size, Sinovac continues to expand its presence in both domestic and international markets, while facing competition from other vaccine manufacturers.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.cdibp.com.cn/
Main Product : Biological products, vaccines, blood products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a renowned company specializing in the production of biological products, vaccines, and blood products. With over 50 years of experience, the company has established itself as a leader in the industry, serving both domestic and international markets. Their commitment to quality and innovation has made them a trusted name in the field of biological products.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : 1992
website : http://www.btbp.com.cn/
Main Product : vaccines, blood products, and diagnostic reagents
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is a reputable company specializing in the production of vaccines, blood products, and diagnostic reagents. Established in 1992, the company has grown to become a leading manufacturer in China with a strong presence in the Asia-Pacific region and Africa. With a medium-sized company size, Beijing Tiantan Biological Products Co., Ltd. is known for its advanced R&D capabilities and high-quality products. Visit their website for more information: http://www.btbp.com.cn/
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2002
website : http://www.cd-biotech.com/
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the research, development, and production of probiotics, enzymes, and feed additives. Founded in 2002, the company has grown to become a key player in the industry, serving customers in China, Southeast Asia, and Europe. With a medium-sized workforce, the company prides itself on its innovative products and commitment to quality. Despite facing competition from both domestic and international companies, Liaoning Chengda Biotechnology Co., Ltd. continues to thrive in the market.
Changchun Changsheng Life Sciences Ltd.
Establishment time : Changchun Changsheng Life Sciences Ltd. was founded in 1992 and has since become a major player in the biopharmaceutical industry.
website :
Main Product : With a large company size, Changchun Changsheng Life Sciences Ltd. has established itself as a key player in the industry.
Company Profile
Changchun Changsheng Life Sciences Ltd. remains committed to innovation and quality, aiming to maintain its position as a key player in the biopharmaceutical industry.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1993.
website :
Main Product : With a large company size, Hualan Biological Engineering Inc. is a key player in the biopharmaceutical industry.
Company Profile
Hualan Biological Engineering Inc. continues to be a leader in the field of biotechnology, driving advancements in healthcare and disease prevention.
